M. A. Yatsko
Research Subjects
M. A. Yatsko has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A. V. Korzinina
Order of the Red Banner of Labor Medical institute named after S.I. Georgievsky V.I. Vernadsky Crimean Federal University
1 shared publication - Eugene D. Kumelskiy
V.I. Vernadsky Crimean Federal University
1 shared publication - I. G. Ulchenko
Order of the Red Banner of Labor Medical institute named after S.I. Georgievsky V.I. Vernadsky Crimean Federal University
1 shared publication - Igor A. Yatskov
S. Georgievsky Medical Institute, V. Vernadsky Crimean Federal University
1 shared publication - L. N. Emiruseinov
Order of the Red Banner of Labor Medical institute named after S.I. Georgievsky V.I. Vernadsky Crimean Federal University
1 shared publication O. S. Tretyakova
Order of the Red Banner of Labor Medical institute named after S.I. Georgievsky V.I. Vernadsky Crimean Federal University
1 shared publication
Latest Publications
- 23 December 2025
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 98
Dynamics of bronchial asthma morbidity in Crimea
Aim . To assess the dynamics and age-specific patterns of bronchial asthma (BA) morbidity in the Republic of Crimea from 2017 to 2024. Materials and methods . Data from the official statistical reporting form No. 12 ("Information on the Number of Diseases Registered Among Patients Residing in the Service Area of a Medical Organization") for the years 2017–2024 were analyzed. Regression analysis was used to quantitatively evaluate trends in BA morbidity. Results . Overall BA morbidity increased from 796,570/0000 in 2017 to 936,16 0/0000 in 2024. Primary incidence rose from 37,430/0000 to 53,780/0000 over the same period. Age-specific trends varied: in the post-pandemic period, both overall and primary incidence declined among children and adolescents (0–14 and 15–17 years), whereas a clear increase was observed in adults aged 18–59 and those aged 60+. Regression analysis confirmed a statistically significant annual increase in BA incidence during the study period (β = 355.3 cases per year; p < 0.001). Conclusion . Crimea has demonstrated a consistent upward trend in both overall and primary BA morbidity. Pre-pandemic years showed rising rates across all age groups. During the pandemic, primary incidence continued to increase while overall morbidity remained stable. In the post-pandemic period, incidence rose among adults (>18 years) but declined in those under 18 years of age.
- 23 December 2025
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 98
Dynamics of bronchial asthma morbidity in Crimea
Aim . To assess the dynamics and age-specific patterns of bronchial asthma (BA) morbidity in the Republic of Crimea from 2017 to 2024. Materials and methods . Data from the official statistical reporting form No. 12 ("Information on the Number of Diseases Registered Among Patients Residing in the Service Area of a Medical Organization") for the years 2017–2024 were analyzed. Regression analysis was used to quantitatively evaluate trends in BA morbidity. Results . Overall BA morbidity increased from 796,570/0000 in 2017 to 936,16 0/0000 in 2024. Primary incidence rose from 37,430/0000 to 53,780/0000 over the same period. Age-specific trends varied: in the post-pandemic period, both overall and primary incidence declined among children and adolescents (0–14 and 15–17 years), whereas a clear increase was observed in adults aged 18–59 and those aged 60+. Regression analysis confirmed a statistically significant annual increase in BA incidence during the study period (β = 355.3 cases per year; p < 0.001). Conclusion . Crimea has demonstrated a consistent upward trend in both overall and primary BA morbidity. Pre-pandemic years showed rising rates across all age groups. During the pandemic, primary incidence continued to increase while overall morbidity remained stable. In the post-pandemic period, incidence rose among adults (>18 years) but declined in those under 18 years of age.